Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus

被引:63
作者
Ryu, JK [1 ]
McLarnon, JG [1 ]
机构
[1] Univ British Columbia, Fac Med, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
关键词
Alzheimer's disease; blood-brain barrier; astrocytes; amyloid beta-peptide; inflammation; microglia/macrophages; minocycline; 1400W;
D O I
10.1016/j.expneurol.2005.12.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This work has examined levels of 3-nitrotyrosine (3-NT, a marker for peroxynitrite formation) and intactness of blood-brain barrier (BBB) in amyloid beta-peptide (A beta(1-42))-injected rat hippocampus. Immunohistochemical analysis demonstrated 3-NT immunoreactivity in microglia/macrophages and astrocytes were significantly increased at 7 days post-A beta(1-42) injection. Administration of the broad spectrum anti-inflammatory agent minocycline or the selective NOS inhibitor 1400W markedly reduced 3-NT levels. Double immunofluorescence staining showed that 3-NT was prominently expressed in microglia/macrophages and astrocytes located in proximity to blood vessels. Additionally, A beta(1-42) injection caused a marked increase in permeability of the BBB to immunoglobulin G (IgG); both minocycline and 1400W were highly effective in decreasing the leakiness of the BBB. Our results suggest the involvement of glial-derived reactive nitrogen species in mediating increased BBB permeability in A beta(1-42) injected rat hippocampus. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:552 / 557
页数:6
相关论文
共 24 条
[1]   The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease [J].
Aisen, PS .
LANCET NEUROLOGY, 2002, 1 (05) :279-284
[2]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[3]   Proteomic identification of nitrated proteins in Alzheimer's disease brain [J].
Castegna, A ;
Thongboonkerd, V ;
Klein, JB ;
Lynn, B ;
Markesbery, WR ;
Butterfield, DA .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) :1394-1401
[4]  
Combs CK, 2001, J NEUROSCI, V21, P1179
[5]  
DeVries HE, 1997, PHARMACOL REV, V49, P143
[6]   Neuroprotection by tetracyclines [J].
Domercq, M ;
Matute, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (12) :609-612
[7]   Cerebral microvascular pathology in aging and Alzheimer's disease [J].
Farkas, E ;
Luiten, PGM .
PROGRESS IN NEUROBIOLOGY, 2001, 64 (06) :575-611
[8]   The blood-brain barrier/neurovascular unit in health and disease [J].
Hawkins, BT ;
Davis, TP .
PHARMACOLOGICAL REVIEWS, 2005, 57 (02) :173-185
[9]   Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice [J].
Heneka, MT ;
Sastre, M ;
Dumitrescu-Ozimek, L ;
Hanke, A ;
Dewachter, I ;
Kuiperi, C ;
O'Banion, K ;
Klockgether, T ;
Van Leuven, F ;
Landreth, GE .
BRAIN, 2005, 128 :1442-1453
[10]  
Hensley K, 1998, J NEUROSCI, V18, P8126